Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judit Morello

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
European Journal of Pharmacology|July 12, 2025
Defining core concepts in pharmacokinetics for undergraduate medical education through a multidisciplinary approachLuísa Teixeira-Santos, Teresa Monteiro, Cátia Sousa, et al.
HIV Clinical Trials|October 27, 2010
Simplification from protease inhibitors to once- or twice-daily raltegravir: the ODIS trialEugenia Vispo, Pablo Barreiro, Ivana Maida, et al.
High-Throughput|April 26, 2019
The mercapturomic profile of health and non-communicable diseasesClara Gonçalves-Dias, Judit Morello, Valdir Semedo, et al.
AIDS Research and Human Retroviruses|April 1, 2008
Association between tipranavir plasma levels and virological response in HIV-infected patientsJudit Morello, Pilar Garcia Gascó, Sonia Rodriguez-Novoa, et al.
Archives of Toxicology|April 19, 2025
Biotransformation of ketamine in terminal in vivo experiments under chronic intermittent hypoxia conditions and the role of AhRAntónio B Pimpão, Luísa Teixeira-Santos, Nuno R Coelho, et al.
AIDS Research and Human Retroviruses|May 30, 2008
Switch from ritonavir-boosted to unboosted atazanavir guided by therapeutic drug monitoringSonia Rodríguez-Nóvoa, Judit Morello, Pablo Barreiro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2009
Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic studySonia Rodríguez-Nóvoa, Pablo Labarga, Vincent Soriano, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2009
Use of different inhibitory quotients to predict early virological response to tipranavir in antiretroviral-experienced human immunodeficiency virus-infected patientsJudit Morello, Carmen De Mendoza, Vincent Soriano, et al.
Nephron|January 10, 2019
Mercapturate Pathway in the Tubulocentric Perspective of Diabetic Kidney DiseaseClara Gonçalves-Dias, Judit Morello, M João Correia, et al.
AIDS Research and Human Retroviruses|April 10, 2010
Preemptive erythropoietin plus high ribavirin doses to increase rapid virological responses in HIV patients treated for chronic hepatitis CEugenia Vispo, Pablo Labarga, Josep M Guardiola, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
European Journal of Pharmacology|July 12, 2025
Defining core concepts in pharmacokinetics for undergraduate medical education through a multidisciplinary approachLuísa Teixeira-Santos, Teresa Monteiro, Cátia Sousa, et al.
HIV Clinical Trials|October 27, 2010
Simplification from protease inhibitors to once- or twice-daily raltegravir: the ODIS trialEugenia Vispo, Pablo Barreiro, Ivana Maida, et al.
High-Throughput|April 26, 2019
The mercapturomic profile of health and non-communicable diseasesClara Gonçalves-Dias, Judit Morello, Valdir Semedo, et al.
AIDS Research and Human Retroviruses|April 1, 2008
Association between tipranavir plasma levels and virological response in HIV-infected patientsJudit Morello, Pilar Garcia Gascó, Sonia Rodriguez-Novoa, et al.
Archives of Toxicology|April 19, 2025
Biotransformation of ketamine in terminal in vivo experiments under chronic intermittent hypoxia conditions and the role of AhRAntónio B Pimpão, Luísa Teixeira-Santos, Nuno R Coelho, et al.
AIDS Research and Human Retroviruses|May 30, 2008
Switch from ritonavir-boosted to unboosted atazanavir guided by therapeutic drug monitoringSonia Rodríguez-Nóvoa, Judit Morello, Pablo Barreiro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2009
Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic studySonia Rodríguez-Nóvoa, Pablo Labarga, Vincent Soriano, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2009
Use of different inhibitory quotients to predict early virological response to tipranavir in antiretroviral-experienced human immunodeficiency virus-infected patientsJudit Morello, Carmen De Mendoza, Vincent Soriano, et al.
Nephron|January 10, 2019
Mercapturate Pathway in the Tubulocentric Perspective of Diabetic Kidney DiseaseClara Gonçalves-Dias, Judit Morello, M João Correia, et al.
AIDS Research and Human Retroviruses|April 10, 2010
Preemptive erythropoietin plus high ribavirin doses to increase rapid virological responses in HIV patients treated for chronic hepatitis CEugenia Vispo, Pablo Labarga, Josep M Guardiola, et al.
Pageof 6